Bio-Techne
TECH
#1705
Rank
A$15.69 B
Marketcap
$99.31
Share price
0.45%
Change (1 day)
-13.33%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

P/S ratio for Bio-Techne (TECH)

P/S ratio as of March 2025 (TTM): 8.16

According to Bio-Techne's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.70. At the end of 2024 the company had a P/S ratio of 9.70.

P/S ratio history for Bio-Techne from 2001 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20249.70-9.03%
202310.7-8.26%
202211.6-41.16%
202119.728.67%
202015.335.99%
201911.340.86%
20188.01-1.07%
20178.1011.46%
20167.260.94%
20157.20-14.26%
20148.39-20.67%
201310.631.29%
20128.06-2.18%
20118.24-7.85%
20108.94-7.32%
20099.657.08%
20089.01-16.95%
200710.85.15%
200610.3-9.54%
200511.419.31%
20049.56-5.57%
200310.117.54%
20028.61-31.35%
200112.5

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
4.65-42.98%๐Ÿ‡บ๐Ÿ‡ธ USA
2.99-63.41%๐Ÿ‡บ๐Ÿ‡ธ USA
3.14-61.56%๐Ÿ‡บ๐Ÿ‡ธ USA
6.22-23.80%๐Ÿ‡บ๐Ÿ‡ธ USA
4.22-48.29%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
4.85-40.57%๐Ÿ‡บ๐Ÿ‡ธ USA
0.8290-89.84%๐Ÿ‡บ๐Ÿ‡ธ USA